SCHEMBL3520232

SCHEMBL3520232

CC(C)(C)N1CCC(n2c(Br)nc3c(N)ncnc32)CC1

nearest known ligand 0.70

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 16/20 0.70
▸ ADORA1 P30542 16/20 0.70
▸ ADORA2B P29275 13/20 0.70
▸ ADORA3 P0DMS8 9/20 0.70
▸ NADK O95544 1/20 0.42
▸ PI4KA P42356 1/20 0.40
▸ PI4K2B Q8TCG2 1/20 0.40
▸ PI4K2A Q9BTU6 1/20 0.40
▸ PI4KB Q9UBF8 1/20 0.40
▸ PDE4A P27815 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ AHCY P23526 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31061415 0.83 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3NADK
SCHEMBL5732373 0.83 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3NADK
SCHEMBL31061173 0.81 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3NADK
SCHEMBL3517750 0.80 ADORA2A (0.59) ADORA2AADORA1ADORA2BADORA3
SCHEMBL3520300 0.79 ADORA2A (0.68) ADORA2AADORA1ADORA2BADORA3NADK
SCHEMBL13731182 0.79 ADORA2A (0.58) ADORA2AADORA1ADORA2BADORA3
SCHEMBL17830246 0.69 MEN1 (0.49) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL8832637 0.67 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL29439771 0.67 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL13731483 0.67 ADORA2A (0.56) ADORA2AADORA1ADORA2BPI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2219448-A1 THERAPEUTIC COMPOUNDS AND THEIR USE IN TREATING DISEASES AND DISORDERS Myriad Pharmaceuticals, Inc. (US) 2010-08-25 — — EP disclosed
WO-2009065035-A1 THERAPEUTIC COMPOUNDS AND THEIR USE IN TREATING DISEASES AND DISORDERS MYRIAD GENETICS, INC. (US) 2009-05-22 — — WO disclosed
Send feedback